Feasibility of allogeneic hematopoietic stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma

References

• Rezvani A R, Storer B, Maris M, Sorror M L, Agura E, Maziarz R T, et al. Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma. J Clin Oncol 2008; 26: 211–217
   PubMed Web of Science ®Google Scholar
• Garvin A J, Simon R M, Osborne C K, Merrill J, Young R C, Berard C W. An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 Cases from the national cancer institute. Cancer 1983; 52: 393–398
   PubMed Web of Science ®Google Scholar
• Hubbard S M, Chabner B A, DeVita Jr VT, Simon R, Berard C W, Jones R B, et al. Histologic progression in non-Hodgkin's lymphoma. Blood 1982; 59: 258–264
   PubMed Web of Science ®Google Scholar
• Bastion Y, Sebban C, Berger F, Felman P, Salles G, Dumontet C, et al. Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J Clin Oncol 1997; 15: 1587–1594
   PubMed Web of Science ®Google Scholar
• Yuen A R, Kamel O W, Halpern J, Horning S J. Long-term survival after histologic transformation of low-grade follicular lymphoma. J Clin Oncol 1995; 13: 1726–1733
   PubMed Web of Science ®Google Scholar
• Lerner R E, Burns L J. Transformed lymphoma: an Achilles' heel of non-Hodgkin's lymphoma. Bone Marrow Transplant 2003; 31: 531–537
   PubMed Web of Science ®Google Scholar
• Risdall R, Hoppe R T, Warnke R. Non-Hodgkin's lymphoma: a study of the evolution of the disease based upon 92 autopsied cases. Cancer 1979; 44: 529–542
   PubMed Web of Science ®Google Scholar
• Acker B, Hoppe R T, Colby T V, Cox R S, Kaplan H S, Rosenberg S A. Histologic conversion in the non-Hodgkin's lymphomas. J Clin Oncol 1983; 1: 11–16
   PubMed Web of Science ®Google Scholar
• Cullen M H, Lister T A, Brearley R I, Shand W S, Stansfeld A G. Histological transformation of non-Hodgkin's lymphoma: a prospective study. Cancer 1979; 44: 645–651
   PubMed Web of Science ®Google Scholar
• Chen C I, Crump M, Tsang R, Stewart A K, Keating A. Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma. Br J Haematol 2001; 113: 202–208
   PubMed Web of Science ®Google Scholar
• Montoto S, Davies A J, Matthews J, Calaminici M, Norton A J, Amess J, et al. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. J Clin Oncol 2007; 25: 2426–2433
   PubMed Web of Science ®Google Scholar
• Armitage J O, Dick F R, Corder M P. Diffuse histiocytic lymphoma after histologic conversion: a poor prognostic variant. Cancer Treat Rep 1981; 65: 413–418
   PubMedGoogle Scholar
• Gallagher C J, Gregory W M, Jones A E, Stansfeld A G, Richards M A, Dhaliwal H S, et al. Follicular lymphoma: prognostic factors for response and survival. J Clin Oncol 1986; 4: 1470–1480
   PubMed Web of Science ®Google Scholar
• Oviatt D L, Cousar J B, Collins R D, Flexner J M, Stein R S. Malignant lymphomas of follicular center cell origin in humans. V. Incidence, clinical features, and prognostic implications of transformation of small cleaved cell nodular lymphoma. Cancer 1984; 53: 1109–1114
   PubMed Web of Science ®Google Scholar
• Philip T, Armitage J O, Spitzer G, Chauvin F, Jagannath S, Cahn J Y, et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med 1987; 316: 1493–1498
   PubMed Web of Science ®Google Scholar
• Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der H Lelie, Bron D, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333: 1540–1545
   PubMed Web of Science ®Google Scholar
• Verdonck L F, van Putten W L, Hagenbeek A, Schouten H C, Sonneveld P, van Imhoff G W, et al. Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N Engl J Med 1995; 332: 1045–1051
   PubMed Web of Science ®Google Scholar
• Schouten H C, Qian W, Kvaloy S, Porcellini A, Hagberg H, Johnson H E, et al. High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial. J Clin Oncol 2003; 21: 3918–3927
   PubMed Web of Science ®Google Scholar
• Rohatiner A Z, Nadler L, Davies A J, Apostolidis J, Neuberg D, Matthews J, et al. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up. J Clin Oncol 2007; 25: 2554–2559
   PubMed Web of Science ®Google Scholar
• Foran J M, Apostolidis J, Papamichael D, Norton A J, Matthews J, Amess J A, et al. High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre. Ann Oncol 1998; 9: 865–869
   PubMed Web of Science ®Google Scholar
• Freedman A S, Ritz J, Neuberg D, Anderson K C, Rabinowe S N, Mauch P, et al. Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma. Blood 1991; 77: 2524–2529
   PubMed Web of Science ®Google Scholar
• Williams C D, Harrison C N, Lister T A, Norton A J, Blystad A K, Coiffier B, et al. High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European bone marrow transplant registry. J Clin Oncol 2001; 19: 727–735
   PubMed Web of Science ®Google Scholar
• Cheson B D, Horning S J, Coiffier B, Shipp M A, Fisher R I, Connors J M, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI sponsored international working group. J Clin Oncol 1999; 17: 1244
   PubMed Web of Science ®Google Scholar
• Przepiorka D, Weisdorf D, Martin P, Klingemann H G, Beatty P, Hows J, et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825–828
   PubMed Web of Science ®Google Scholar
• Hari P, Carreras J, Zhang M J, Gale R P, Bolwell B J, Bredeson C N, et al. Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning. Biol Blood Marrow Transplant 2008; 14: 236–245
   PubMed Web of Science ®Google Scholar
• Novitzky N, Thomas V. Allogeneic stem cell transplantation with T cell-depleted grafts for lymphoproliferative malignancies. Biol Blood Marrow Transplant 2007; 13: 107–115
   PubMed Web of Science ®Google Scholar